AI assistant
Innoviva, Inc. — Director's Dealing 2021
Mar 30, 2021
32090_dirs_2021-03-30_dd553009-e4e5-4b8c-a6c7-c16fc34e6026.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Innoviva, Inc. (INVA)
CIK: 0001080014
Period of Report: 2021-03-29
Reporting Person: Zhen Marianne (Chief Accounting Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-29 | Common Stock | A | 10305 | — | Acquired | 38399 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-29 | Non-statutory Stock Option | $12.13 | A | 5000 | Acquired | 2031-03-29 | Common Stock (5000) | Direct |
Footnotes
F1: The Reporting Person was granted a time-based restricted stock award ("RSA"). Twenty-five percent of the shares subject to the RSA shall vest on February 20, 2022, 6.25% on May 20, 2022, and an additional 6.25% on the final day of each 3-month period thereafter, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. The grant was approved by the Compensation Committee of the Board of Directors of the Company.
F2: The Reporting Person was granted options. Twenty-five percent of the options shall vest on February 20, 2022, 6.25% on May 20, 2022, and an additional 6.25% on the final day of each 3-month period thereafter, provided the Reporting Person has provided continuous service to the Issuer through the applicable vesting date. The grant was approved by the Compensation Committee of the Board of Directors of the Company.